D'Arrigo R - Search Results

1

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Ciancio BC, Trotta MP, Lorenzini P, Forbici F, Visco-Comandini U, Gori C, Bonfigli S, Bellocchi MC, Sette P, D'Arrigo R, Tozzi V, Zaccarelli M, Boumis E, Narciso P, Perno CF, Antinori A. Ciancio BC, et al. Antivir Ther. 2003 Dec;8(6):611-6. Antivir Ther. 2003. PMID: 14760895

2

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A, Antinori A. Zaccarelli M, et al. Antivir Ther. 2003 Feb;8(1):51-6. Antivir Ther. 2003. PMID: 12713064

3

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy.

Zaccarelli M, Perno CF, Forbici F, Soldani F, Bonfigli S, Gori C, Trotta MP, Bellocchi MC, Liuzzi G, D'Arrigo R, De Longis P, Boumis E, Bellagamba R, Tozzi V, Narciso P, Antinori A. Zaccarelli M, et al. Clin Infect Dis. 2004 Feb 1;38(3):433-7. doi: 10.1086/381097. Epub 2004 Jan 6. Clin Infect Dis. 2004. PMID: 14727218

4

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Tozzi V, Zaccarelli M, Narciso P, Trotta MP, Ceccherini-Silberstein F, De Longis P, D'Offizi G, Forbici F, D'Arrigo R, Boumis E, Bellagamba R, Bonfigli S, Carvelli C, Antinori A, Perno CF. Tozzi V, et al. J Infect Dis. 2004 May 1;189(9):1688-95. doi: 10.1086/382960. Epub 2004 Apr 13. J Infect Dis. 2004. PMID: 15116307 Clinical Trial.

5

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.

Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF. Bellocchi MC, et al. J Med Virol. 2005 Aug;76(4):452-8. doi: 10.1002/jmv.20382. J Med Virol. 2005. PMID: 15977236

6

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir.

Trotta MP, Bonfigli S, Ceccherini-Silberstein F, Bellagamba R, D'Arrigo R, Soldani F, Zaccarelli M, Concetta Bellocchi M, Lorenzini P, Marconi P, Boumis E, Forbici F, Comandini UV, Tozzi V, Narciso P, Federico Perno C, Antinori A. Trotta MP, et al. J Med Virol. 2006 May;78(5):535-41. doi: 10.1002/jmv.20573. J Med Virol. 2006. PMID: 16555278

7

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.

Santoro MM, Svicher V, Gori C, Zaccarelli M, Tozzi V, Forbici F, D'Arrigo R, Trotta MP, Bellocchi MC, Visco-Comandini U, Cenci A, Bertoli A, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F. Santoro MM, et al. New Microbiol. 2006 Apr;29(2):89-100. New Microbiol. 2006. PMID: 16841549

8

Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.

Tozzi V, Bellagamba R, Castiglione F, Amendola A, Ivanovic J, Nicastri E, Libertone R, D'Offizi G, Liuzzi G, Gori C, Forbici F, D'Arrigo R, Bertoli A, Salvatori MF, Capobianchi MR, Antinori A, Perno CF, Narciso P. Tozzi V, et al. AIDS Res Hum Retroviruses. 2008 Jun;24(6):787-96. doi: 10.1089/aid.2007.0236. AIDS Res Hum Retroviruses. 2008. PMID: 18507523

9

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.

Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani". Zaccarelli M, et al. Infection. 2009 Jun;37(3):203-9. doi: 10.1007/s15010-008-8142-8. Epub 2009 Mar 9. Infection. 2009. PMID: 19274429

10

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir.

Tommasi C, Ceccherini-Silberstein F, D'Arrigo R, Bellagamba R, Tempestilli M, Dessì C, Santoro MM, Forbici F, Nicastri E, Pucillo LP, Perno CF, Narciso P. Tommasi C, et al. Scand J Infect Dis. 2010 Mar;42(3):237-9. doi: 10.3109/00365540903447018. Scand J Infect Dis. 2010. PMID: 20085429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters